Ariel Investments LLC Purchases 144,541 Shares of CVS Health Corporation $CVS

Ariel Investments LLC lifted its holdings in CVS Health Corporation (NYSE:CVS) by 14.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,164,574 shares of the pharmacy operator’s stock after acquiring an additional 144,541 shares during the period. Ariel Investments LLC owned approximately 0.09% of CVS Health worth $80,332,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Avion Wealth increased its holdings in CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. acquired a new stake in shares of CVS Health during the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc increased its stake in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares in the last quarter. Roxbury Financial LLC lifted its position in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 202 shares during the period. Finally, ORG Partners LLC boosted its stake in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares in the last quarter. Institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

CVS opened at $78.31 on Wednesday. The firm’s fifty day moving average price is $78.82 and its two-hundred day moving average price is $71.59. The company has a market capitalization of $99.41 billion, a price-to-earnings ratio of 206.08, a P/E/G ratio of 0.75 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $85.15.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping the consensus estimate of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period in the previous year, the company earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio (DPR) is presently 700.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Truist Financial reiterated a “buy” rating and set a $95.00 price objective (up previously from $92.00) on shares of CVS Health in a report on Thursday, October 30th. The Goldman Sachs Group initiated coverage on CVS Health in a research report on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 14th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research note on Monday. Finally, Barclays upped their target price on CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $91.67.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.